Contraception and Infertility Research Loan Repayment Program

 

The CIR-LRP is designed to provide an incentive for health professionals to work in areas of reproductive extramural contraception and/or infertility research (which are defined, respectively, as research that has the ultimate goal to provide new or improved methods of preventing pregnancy and research that has long-range objective to evaluate, treat, or ameliorate conditions which result in the failure of couples to either conceive or bear young) by repaying educational loans. The CIR-LRP will pay up to $50,000 ($20,000 for ACGME fellowa) of the principal of a participant's educational loans for each year of commitment not to exceed 25% of the remaining loan balance. LRP loan repayments are considered taxable income and can significantly affect an awardee's taxable income. To offset the tax burden resulting from LRP repayments, the LRPs also make a tax payment to the Internal Revenue Service (IRS) equal to 39 percent of the annual LRP repayment. In return for these loan repayments, awardees must agree to conduct contraception and/or infertility research for not less than one year for each year of support awarded. The long- range objective of the CIR-LRP is to stimulate the commitment of researchers to sustaining a career focus on contraception and/or infertility research, as defined above.

Deleted 03/27/2024 (Archived.) 93.209 National Institutes of Health, Department of Health and Human Services C - Direct Payments For Specified Use Fiscal Year 2016 In fiscal year 2016, the projected funding level for the Contraception and Infertility Research LRP is $980,000 with a projected total of 23 contracts. In fiscal year 2016, the actual funding level for the Contraception and Infertility Research LRP was $995,110 with a total of 16 contracts.
Fiscal Year 2017 In fiscal year 2017, the projected funding level for the Contraception and Infertility Research LRP is $1,023,550 with a projected total of 16 contracts.
Fiscal Year 2019 In fiscal year 2019, the projected funding level for the Contraception and Infertility Research LRP is $1,137,000 with a projected total of 21 contracts.
Fiscal Year 2020 In fiscal year 2020, the projected funding level for the Contraception and Infertility Research LRP is $974,000 with a projected total of 18 contracts. Public Health Service Act, 42 U.S.C. 288-2, Title IV (National Research Institutes), Part G (Awards and Training), Section 487B (Loan Repayment Program for Research with Respect to Contraception and Infertility), as amended by Public Law 113-235. Applicants must be a U.S. citizen (or U.S. national or permanent resident) In addition to doctoral-level degrees, applications will be considered from other allied health professionals including nurses, physician assistants, graduate students, or postgraduate research fellows training in a health profession. Applicants for new awards must commit to conduct contraception and infertility research for at least 50% of their time (at least 20 hours weekly based on a 40 hour week) for two years and it must be funded by a domestic nonprofit or U.S. Government (Federal, state or local) entity. Also, the research must not be prohibited by Federal law or NIH policy. Complete eligibility information is available at https://grants.nih.gov/grants/guide/notice-files/NOT-OD-19-120.html Assistance in the form of loan repayments will be made to the lender of participants in the CIR-LRP. In order to be considered for selection into the CIR-LRP, eligible new applicants must complete and submit the electronic application materials located at www.lrp.nih.gov, which include: (1) a Loan Verification Form for each loan to be considered for repayment; (2) an institutional statement providing assurance that the applicant will be engaged in employment/training at a qualified domestic nonprofit institution (tax-exempt under 26 USC 501) or U.S federal, state or local government entity, for not less than two years from the anticipated effective date of the NIH Loan Repayment Program Contract between the individual and NICHD (this assurance is conducted electronically); and (3) a signed NIH Loan Repayment Program Contract by which the applicant agrees to serve the obligated minimum period, one year for each year of support awarded, conducting contraception and/or infertility research at a qualified domestic nonprofit institution (tax-exempt under 26 USC 501). Renewal applicants may request one or two year awards. For these applicants, a one-year "institutional statement providing assurance" and "NIH Loan Repayment Program Contract" is sufficient. Preapplication coordination is required. Information regarding the CIR-LRP and the preparation of forms for application to the CIR-LRP can be obtained at https://grants.nih.gov/grants/guide/notice-files/NOT-OD-19-120.html and by contacting the LRP Info Center at www.lrp.nih.gov, (866) 849-4047 (Mon-Fri 9AM - 5PM Eastern Time) and lrp@nih.gov. 2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards applies to this program. Qualified individuals interested in participating in the CIR-LRP should visit the NIH Loan Repayment Program Website at www.lrp.nih.gov for all application forms and requirements. The application will be evaluated by a Review Committee, convened for this purpose by the Scientific Review Branch, NICHD, NIH, HHS. In selecting applicants for participation in the CIR-LRP, the panel will consider the review criteria listed under "Application Review Process" at https://www.lrp.nih.gov/faqs. All selections are subject to final approval by the Director, NICHD. The NIH Division of Loan Repayment will notify the applicant of the outcome of the review. Once the applicant is selected to participate in the CIR-LRP, the applicant and the Director, NICHD, as a designee of the Secretary of Health and Human Services, will sign a written binding contract stating the terms and conditions for participating in the CIR- LRP. The effective date of the contract will be the date it is signed by the Director, NICHD, or the date employment/training begins at an NICHD-funded Specialized Contraception or Infertility Research Center, whichever is later. September 1, 2019 to November 15, 2019 Applications can be received at the deadlines established and announced each year at http://www.lrp.nih.gov/. Approximately 330 Days. The selection process takes approximately 11 months following the application deadline. Not applicable. Not applicable. Review criteria for all CIR LRP applications are listed under "Application Review Process" at https://www.lrp.nih.gov/faqs In addition, CIR LRP renewal applications are reviewed with respect to the following criteria: (1) Assessment of the renewal applicant's research accomplishments during the previous LRP award period and (2) Assessment of the renewal applicant's development as an independent investigator. The assistance provided by the CIR-LRP is entirely of a financial nature in the form of loan repayments. The monies provided by this program are restricted to the repayment of pre-existing, qualified loans procured by the participant for educational expenses incurred in the pursuit of undergraduate or graduate degrees. Not applicable. Not applicable. None. Statutory formula is not applicable to this assistance listing.

Matching requirements are not applicable to this assistance listing.

MOE requirements are not applicable to this assistance listing. The CIR-LRP will pay equal quarterly payments to the lenders. Each payment will be made shortly after the end of each full quarter of satisfactory service. Method of awarding/releasing assistance: Quarterly. None/Not specified. Steven C. Kaufman, M.D., M.S.
6710B Rockledge Drive, room 2421C
Bethesda, MD 20817 US
kaufmans@mail.nih.gov
Phone: 301-496-8363
Fax: 301-480-3901 https://www.lrp.nih.gov 75-0844-0-1-552 (Direct Payments for Specified Use) FY 18$1,088,000.00; FY 19 est $1,037,000.00; FY 20 est $974,000.00; FY 17$1,090,000.00; FY 16$995,110.00; - In fiscal year 2018 the range of financial assistance was between $10,839 and $97,300. The average contract cost was $72,549. The Notice of Proposed Rulemaking was approved by NIH on September 19, 2001, and by the Department of Health and Human Services on December 31, 2001. Not applicable.